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Context: Although numerous studies have examined
the role of latent variables in the structure of comorbid-
ityamongmentaldisorders,nonehasexaminedtheirrole
in the development of comorbidity.
Objective: To study the role of latent variables in the
development of comorbidity among 18 lifetime DSM-IV
disordersintheWorldHealthOrganizationWorldMen-
tal Health Surveys.
Design: Nationally or regionally representative com-
munity surveys.
Setting: Fourteen countries.
Participants: A total of 21229 survey respondents.
Main Outcome Measures: First onset of 18 lifetime
DSM-IV anxiety, mood, behavior, and substance disor-
ders assessed retrospectively in the World Health Orga-
nization Composite International Diagnostic Interview.
Results: Separate internalizing (anxiety and mood dis-
orders) and externalizing (behavior and substance dis-
orders) factors were found in exploratory factor analy-
sisoflifetimedisorders.Consistentlysignificantpositive
time-lagged associations were found in survival analy-
ses for virtually all temporally primary lifetime disor-
ders predicting subsequent onset of other disorders.
Within-domain(ie,internalizingorexternalizing)asso-
ciations were generally stronger than between-domain
associations. Most time-lagged associations were ex-
plained by a model that assumed the existence of medi-
atinglatentinternalizingandexternalizingvariables.Spe-
cific phobia and obsessive-compulsive disorder
(internalizing) and hyperactivity and oppositional defi-
antdisorders(externalizing)werethemostimportantpre-
dictors. A small number of residual associations re-
mained significant after controlling the latent variables.
Conclusions:Thegoodfitofthelatentvariablemodelsug-
geststhatcommoncausalpathwaysaccountformostofthe
comorbidityamongthedisordersconsideredherein.These
common pathways should be the focus of future research
on the development of comorbidity, although several im-
portantpairwiseassociationsthatcannotbeaccountedfor
bylatentvariablesalsoexistthatwarrantfurtherfocusedstudy.
Arch Gen Psychiatry. 2011;68(1):90-100
C
OMORBIDITY IS THE NORM
among common mental
disorders because more
than 50% of people with
a mental disorder in a
given year meet criteria for multiple dis-
orders.1,2 The structure of this comorbid-
ityhasbeenthesubjectofconsiderablein-
terest.Beginningwithaninfluentialarticle
by Krueger,3 numerous researchers have
documented that bivariate associations
among hierarchy-free anxiety, mood, be-
havior,andsubstancedisorderscanbeac-
countedforbycorrelatedlatentpredispo-
sitions to internalizing and externalizing
disorders, with division of internalizing
disordersintosecondarydimensionsoffear
(eg, panic and phobia) and distress (eg,
major depressive episode and general-
ized anxiety disorder).4-9
Theseresultshavebeenusedtoarguefor
areorganizationoftheclassificationofmen-
tal disorders in the DSM and International
Classification of Disease diagnostic sys-
tems.10-13 However, additional work is
neededtoevaluatetheempiricalsupportfor
such a reorganization because the frame-
work has only recently been expanded to
include additional forms of psychopathol-
ogy,suchaspsychoticexperiences.14More-
over,additionalresearchonthestabilityof
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sex, and education) would be informative.
Theseresultshavealsobeenusedoccasionallytoinves-
tigatewhetherriskfactorsforindividualdisordersaremore
accurately conceptualized as risk factors for the latent di-
mensions underlying these disorders. Kramer and col-
leagues,15forexample,foundthatobservedsexdifferences
inseveralinternalizingandexternalizingdisordersbecame
statistically insignificant when controls were included for
latentinternalizing-externalizingdimensions.Suchevidence
canbevaluableindistinguishingbetweenspecificandnon-
specificriskfactors.Theuseoflatentvariablemodelsinthis
wayisonlyinitsinfancy.Oneobviousapplicationistothe
developmentofcomorbidityitself.Inparticular,although
thecross-sectionalstructureofcomorbidityhasbeenexam-
inedinanumberofstudies,weareunawareofattemptsto
investigate the role of latent dimensions in accounting for
the development of comorbidity.
Although several studies used longitudinal data to de-
termine whether the structure of internalizing and exter-
nalizing disorders is stable over time,9,16,17 none investi-
gated whether this structure accounts for the associations
between temporally primary disorders and the subse-
quentfirstonsetofcomorbiddisorders.Anumberofother
longitudinalstudiesexaminedtemporalprogression18,19or
sequencing20-23 between earlier and later mental disor-
ders, documenting strong persistence of individual disor-
ders over time and significant predictive associations be-
tween some but not other temporally primary and later
disorders.Forexample,Fergussonandcolleagues18found
thatchildhoodconductdisorderbutnotattention-deficit/
hyperactivitydisorder(ADHD)predictedsubsequentsub-
stance disorders. None of these studies, however, investi-
gated whether associations of earlier disorders with onset
of later disorders were mediated by latent variables.
Analysis of the latter sort could be useful in identifying
potentially modifiable risk pathways by focusing atten-
tion on subsets of disorders with especially strong predic-
tive associations that could subsequently be examined in
morefocusedanalyses.24,25Forexample,clinicalstudiesfind-
ingchildhoodimpulse-controlproblemsinasubsetofpa-
tients with early-onset obsessive-compulsive disorder
(OCD)26,27andfindingthatimpulse-controldisorderscon-
tinuetofeatureprominentlyinsomecasesofadultOCD28,29
have created interest in the importance of inhibitory dys-
control in the pathogenesis of OCD.30 However, the role
of putative neurobiological markers of such dyscontrol in
accounting for the associations of impulse-control disor-
derswithsubsequentOCDremainsunstudied.Thedocu-
mentation in epidemiological data of special associations
between a cluster of early-onset impulse-control disor-
ders and subsequent OCD could help spur such research
bysuggestingthatmorefocusedprospectiveneurobiologi-
calstudiesofthisclusterbeginninginchildhoodmightyield
valuable information about an important OCD subtype.
Thepresentreportproposesanovelapproachtoinves-
tigatetheroleoflatentvariablesinthedevelopmentofco-
morbidity. We begin with a conventional survival analy-
sisofepidemiologicaldatacollectedin14countriesinthe
WorldHealthOrganization(WHO)WorldMentalHealth
(WMH) Survey Initiative31 to study associations between
earlier lifetime disorders and the subsequent first onset of
later disorders. We then elaborate these survival models
using a new latent modeling approach to examine the ex-
tent to which the associations among observed disorders
can be accounted for by the mediating effects of latent in-
ternalizing and externalizing variables.
METHODS
SAMPLES
The14WMHcountriesinclude7classifiedbytheWorldBank
as developed (Belgium, France, Germany, Italy, the Nether-
lands, Spain, and the United States) and 7 classified as devel-
oping (Brazil, Colombia, India, Lebanon, Mexico, the Peoples’
RepublicofChina,andRomania)(Table 1).Surveysweread-
ministered in multistage, clustered area probability house-
hold samples representative of specific regions within coun-
tries(Brazil,Colombia,India,Mexico,andthePeoples’Republic
of China) or entire countries (the remaining countries). Re-
spondents were interviewed face-to-face by trained lay inter-
viewers who explained the purposes of the survey, made clear
that participation was voluntary and that responses would be
treated as confidential, and obtained informed consent before
beginning interviews. These recruitment and consent proce-
dures were approved by the local human subjects committee
that monitored the study in each country. A total of 61292 re-
spondents were interviewed. Country-specific response rates
ranged from 45.9% (France) to 98.6% (India). The weighted
(by sample size) average response rate was 71.1%.
Theinterviewwasdividedinto2parts.Part1assessedcore
disorders and was completed by all respondents. Part 2 as-
sessed additional disorders and numerous correlates and was
completed by 100% of respondents who met criteria for any
part 1 disorder plus a probability subsample of other part 1 re-
spondents. Based on a concern about recall bias, disorders de-
finedasbeginninginchildhood(ADHD,conductdisorder,op-
positional defiant disorder [ODD], and separation anxiety
disorder)wereassessedonlyamongrespondentsaged18to44
years. This part 2 subsample, which ranges in size from 486
respondentsinBelgiumto6218inthePeoples’RepublicofChina
and totals 21229 respondents across countries, is the sample
used in the present report. The part 1 samples were weighted
to adjust for differential probabilities of selection and residual
discrepancies between sample and census on sociodemo-
graphicandgeographicvariables.Inaddition,thepart2samples
were weighted to adjust for undersampling of part 1 respon-
dents without part 1 disorders. A more detailed discussion of
WMH sampling and weighting is presented elsewhere.32
DIAGNOSTIC ASSESSMENT
Diagnoseswerebasedonversion3.0oftheWHOCompositeIn-
ternationalDiagnosticInterview(CIDI),33afullystructured,lay-
administered interview that generates diagnoses according to
ICD-10andDSM-IVcriteria.TheDSM-IVcriteriaareusedherein.
Translation and back-translation followed standard WHO pro-
cedures.34The7-dayinterviewertrainingprogramwasstandard-
izedacrosscountries.Trainingculminatedinanexaminationthat
had to be passed before the interviewer could begin production
datacollection.AmoredetaileddiscussionofWMHtrainingand
quality control is presented elsewhere.35
The 18 lifetime diagnoses include mood disorders (bipolar
I-II or subthreshold disorder [BPD] and major depressive epi-
sode/dysthymia),anxietydisorders(agoraphobiawithorwith-
outpanicdisorder,generalizedanxietydisorder[GAD],OCD,
panicdisorderwithorwithoutagoraphobia,posttraumaticstress
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specific phobia), behavior disorders (attention-deficit disor-
der[ADD],hyperactivitydisorder[HD],conductdisorderwith
covert symptoms [CD1; eg, lying, shoplifting], conduct disor-
der with overt symptoms [CD2; eg, bullying, being physically
cruel to people], intermittent explosive disorder [IED], and
Table 1. WMH Survey Sample Characteristics
Country Surveya Sample Design
Field
Dates
Age
Range, y
Sample Size
Response
Rate, %b Part 1 Part 2
Part 2 and
Aged
18-44 ya
Developed Countries
Belgium ESEMeD Stratified multistage clustered probability sample of
individuals residing in households from the national
register of Belgium residents; NR
2001-2002 18 2419 1043 486 50.6
France ESEMeD Stratified multistage clustered sample of working
telephone numbers merged with a reverse directory
(for listed numbers); initial recruitment was by
telephone, with supplemental in-person recruitment
in households with listed numbers; NR
2001-2002 18 2894 1436 727 45.9
Germany ESEMeD Stratified multistage clustered probability sample of
individuals from community resident registries; NR
2002-2003 18 3555 1323 621 57.8
Italy ESEMeD Stratified multistage clustered probability sample of
individuals from municipality resident registries; NR
2001-2002 18 4712 1779 853 71.3
The Netherlands ESEMeD Stratified multistage clustered probability sample of
individuals residing in households listed in
municipal postal registries; NR
2002-2003 18 2372 1094 516 56.4
Spain ESEMeD Stratified multistage clustered area probability sample
of household residents; NR
2001-2002 18 5473 2121 960 78.6
United States NCS-R Stratified multistage clustered area probability sample
of household residents; NR
2002-2003 18 9282 5692 3197 70.9
Total 30707 14488 7360 63.8
Developing Countries
Brazil Sa ˜o Paulo
Megacity
Stratified multistage clustered area probability sample
of household residents in the Sa ˜o Paulo
metropolitan area
2004-2007 18 5037 2942 1824 81.3
Colombia NSMH Stratified multistage clustered area probability sample
of household residents in all urban areas of the
country (approximately 73% of the total national
population)
2003 18-65 4426 2381 1731 87.7
India WMHI Stratified multistage clustered area probability sample
of household residents in Pondicherry region; NR
2003-2005 18 2992 1373 825 98.6
Lebanon LEBANON Stratified multistage clustered area probability sample
of household residents; NR
2002-2003 18 2857 1031 595 70.0
Mexico M-NCS Stratified multistage clustered area probability sample
of household residents in all urban areas of the
country (approximately 75% of the total national
population)
2001-2002 18-65 5782 2362 1736 76.6
PRC Shenzhen Stratified multistage clustered area probability sample
of household residents and temporary residents in
the Shenzhen area
2006-2007 18 7134 7134c 6218c 80.0
Romania RMHS Stratified multistage clustered area probability sample
of household residents; NR
2005-2006 18 2357 2357 940 70.9
Total 30585 19580 13869 80.2
Total for All
Countries
61292 34068 21229 71.1
Abbreviations: ESEMeD, European Study of the Epidemiology of Mental Disorders; LEBANON, Lebanese Evaluation of the Burden of Ailments and Needs of the
Nation; M-NCS, Mexico National Comorbidity Survey; NCS-R, US National Comorbidity Survey Replication; NR, nationally representative; NSMH, Colombian
National Study of Mental Health; PRC, People’s Republic of China; RMHS, Romania Mental Health Survey; WMH, World Mental Health; WMHI, WMH India.
aMost WMH surveys are based on stratified multistage clustered area probability household samples in which samples of areas equivalent to counties or
municipalities in the United States were selected in the first stage followed by 1 or more subsequent stages of geographic sampling (eg, towns within counties,
blocks within towns, households within blocks) to arrive at a sample of households, in each of which a listing of household members was created and 1 or 2
people were selected from this listing to be interviewed. No substitution was allowed when the originally sampled household resident could not be interviewed.
These household samples were selected from census area data in all countries other than France (where telephone directories were used to select households)
and the Netherlands (where postal registries were used to select households). Several WMH surveys (Belgium, Germany, and Italy) used municipal resident
registries to select respondents without listing households. Ten of the 14 surveys are based on NR household samples. The others are representative of particular
cities (Brazil and India) or the urbanized areas of the country (Colombia and Mexico).
bCalculated as the ratio of the number of households in which an interview was completed to the number of households originally sampled, excluding from the
denominator households known not to be eligible because of being vacant at the time of initial contact or because the residents were unable to speak the
designated languages of the survey.
cIn Shenzhen, all respondents received the part 2 interview and all respondents aged 18 through 44 years were used in the current analysis.
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with or without dependence).
As detailed elsewhere,36 blinded clinical reappraisal inter-
views found generally good concordance between DSM-IV diag-
nosesbasedontheCIDIandthosebasedontheStructuredClini-
cal Interview for DSM-IV Axis I Disorders.37 Organic exclusions
but not diagnostic hierarchy rules were used in making diag-
noses.TheCIDIincludedretrospectivedisorderage-at-onsetre-
ports based on a special question sequence that has been shown
experimentally to improve recall accuracy.38 Respondents were
asked to date their age when they first had the full syndrome for
each disorder, not the first symptom of the disorder.
ANALYSIS METHODS
Exploratory principal axis tetrachoric factor analysis with pro-
max rotation was used to examine bivariate comorbidity. Clear
internalizing (10 disorders) and externalizing (8 disorders) di-
mensions were found but no evidence of a third factor that dis-
tinguished fear from distress disorders. Discrete-time survival
analysis39 with person-year as the unit of analysis and a logistic
link function40 was then used to study associations of tempo-
rallyprimarylifetimedisorderswithsubsequentfirstonsetoflater
disorders. Each model predicted first onset of 1 of the 18 DSM-
IV/CIDI disorders from information about prior lifetime occur-
rence of the other 17 disorders (1817=306 pairwise associa-
tions),whichweretreatedastime-varyingcovariates,controlling
for respondent age, sex, and country. Retrospective age-at-onset
reports were used to define the predictor disorders as time vary-
ing and to define age at onset of the outcome disorders.
We then estimated a latent variable model that constrained
the coefficients in the observed variable models to be mediated
byhypothesizedcontinuoustime-varyinglatentinternalizingand
externalizing variables. The coefficients in the observed variable
modelwereconstrainedinthesensethatthismodelincluded306
coefficients (Figure, A), whereas the latent variable model used
only 36 independent coefficients to reproduce these same asso-
ciations (Figure, B). These included 10 coefficients (1 of which
was nonindependent because the 10 coefficients together per-
fectly predict the time t latent variable) for the time t lifetime in-
ternalizingdisorderspredictingthetimetlatentinternalizingvari-
able;8coefficients(1ofwhichwasnonindependentbecausethe
8 coefficients together perfectly predict the time t latent vari-
able)forthetimetlifetimeexternalizingdisorderspredictingthe
timetlatentexternalizingvariable;4coefficients(2ofwhichwere
nonindependent because the pair of time t latent variables per-
fectlypredicteachofthe2timet1latentvariables)forthetime
t latent internalizing and externalizing variables predicting the
time t1 latent internalizing and externalizing variables; 10 co-
efficients for the time t1 latent internalizing variable predict-
ing first onsets of the 10 time t1 internalizing disorders; and 8
coefficients for the time t1 latent externalizing variable pre-
dicting first onsets of the 8 time t1 externalizing disorders.
In interpreting the latent variable results, it is useful to note
thatthelatentvariablesareactuallyweighted(byoddsratios[ORs]
ofdisorderspredictinglatentvariables)compositesofallpredic-
tor disorders. The assumption that a single weighted composite
can represent the effects of all predictor disorders is equivalent
to assuming that the ratios of the ORs across predictors are con-
stant across outcomes. These constraints are the key features of
the model. The standard covariance structure analysis programs
usedinpreviousstudiesofthestructureofcomorbiditycouldnot
be used to impose these constraints because discrete-time sur-
vival analysis is based on a person-year data array that varies in
sizeacrosstheoutcomes.Aniterativemaximum-likelihoodmethod
implemented in a SAS macro was consequently written to esti-
matethecoefficients.41Thisproceduresequentiallyestimatedthe
coefficientsinthe3partsofthemodel(timetobservedvariables
predicting time t latent variables, time t latent variables predict-
ingtimet1latentvariables,andtimet1latentvariablespre-
dicting time t1 observed variables), each time holding con-
stant the coefficients in the other 2 parts of the model to their
values in the previous iteration, until estimates converged.
Once estimated, a likelihood-ratio 2 test was used to com-
pare the fit of the latent variable model and the observed vari-
able model with 270 (306−36) degrees of freedom. As de-
scribed in the “Results” section, the latent variable model
provided a better fit. We also investigated whether any of the
306 pairwise associations remained significant after control-
ling for the latent variables. Simple pairwise tests were inap-
propriate here because separate .05-level tests would generate
more than a dozen false-positive results of 306 tests. The Bon-
ferronimethodanditsextensionsdealwiththisproblem,42but
thesearelow-powerteststhatmakeitdifficulttodetectallbut
the largest true associations.43 We consequently used an inter-
nal subsampling strategy to pinpoint pairwise associations for
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B
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Figure. Model schematics. A, Schematic of the multivariate observed
variable model. Only 3 observed lifetime time t internalizing disorders and
externalizing disorders along with only 1 observed internalizing and 1
observed externalizing disorder at time t1 are shown to simplify the
presentation, but there were 10 observed lifetime internalizing and 8
observed externalizing disorders in the actual survival model at each time
point. First onset of each of these 18 disorders between times t and t1 was
predicted by lifetime history of the other 17 disorders as of time t. Estimation
was made in 18 separate survival equations, each with 17 predictors for
history of the other disorders, for a total of 306 (1817) pairwise
time-lagged associations between earlier and later mental disorders. The 17
predictor disorders were treated as time-varying covariates in a discrete-time
(person-year) survival framework. Controls were also included for
respondent age at interview, sex, person-year, and country. B, Schematic of
the multivariate latent variable model. Only 3 observed lifetime time t
internalizing disorders and externalizing disorders and only 3 disorders of
each set at time t1 are shown to simplify the presentation, but there were
10 observed lifetime internalizing and 8 observed externalizing disorders in
the actual survival model. First onset of each of these 18 disorders between
times t and t1 was predicted by latent internalizing or latent externalizing
variables at time t1. These latent variables, in turn, were predicted by
lifetime history of latent internalizing and externalizing variables as of time t.
These time t latent variables, finally, were predicted by lifetime history of
observed internalizing or externalizing variables as of time t. Estimation was
performed using a 3-part iterative procedure. A total of 36 independent
associations were estimated, 270 fewer than in the model for associations
among observed disorders. As in the earlier observed variable model, the
predictor disorders were treated as time-varying covariates in a discrete-time
(person-year) survival framework, and controls were included for respondent
age at interview, sex, person-year, and country. e indicates externalizing;
i, internalizing. The Greek letters  and ε represent measurement errors in
observed i and e variables, respectively. Lowercase letters signify measured
variables; and uppercase, latent variables.
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modelscontrollingforthelatentvariablesinsubsetsofperson-
years. Rather than use random subsamples, which would sim-
ply have produced patterns determined by the rules of ran-
domsampling,wefocusedonmeaningfullydifferentsubsamples
defined by 4 independent life course stages (childhood, ages
4-12 years; adolescence, ages 13-19 years; young adulthood,
ages20-29years;andmiddleadulthood,ages30-44years)and
considered a given pairwise association substantively signifi-
cant only if it was statistically significant at the .05 level in the
totalsampleandinatleast2independentsubsampleswithcon-
sistent sign patterns and ORs (exponentiated survival coeffi-
cients) greater than or equal to 2.0 or less than or equal to 0.5.
BecausetheWMHdataareclusteredandweighted,thedesign-
based method of jackknife repeated replications44 was used to
calculate standard errors and assess statistical significance. A
SAS macro was used for this purpose.41
RESULTS
EXPLORATORY FACTOR ANALYSIS
Exploratory factor analysis of the 18 lifetime DSM-IV/
CIDIdisorderswasperformedseparatelyindevelopedand
developingcountries.Only2meaningfulfactorswerefound,
with unrotated eigenvalues of 8.0 and 1.8 (in developed
countries)and6.6and2.3(indevelopingcountries).Pro-
max-rotated factor loadings (standardized partial regres-
sioncoefficients)showedthatthefactorscorrespondtoin-
ternalizing and externalizing dimensions (Table 2). All
the mood and anxiety disorders other than BPD loaded
clearlyontheinternalizingfactor(0.43-0.87standardized
regressioncoefficients).Allthebehaviorandsubstancedis-
orders other than IED loaded clearly on the externalizing
factor(0.51-0.94standardizedregressioncoefficients).Bi-
polar disorder cross-loaded in developed countries (0.31-
0.37) and IED in developing countries (0.30-0.48). How-
ever,country-levelanalysesfoundthatBPDgenerallyloaded
more strongly on the internalizing factor and IED on the
externalizingfactor,leadingustoclassifythemwiththese
dimensions in further analyses. (Detailed results are not
reported herein, but are available from the authors on re-
quest.)Separatefactoranalysisofonlytheinternalizingdis-
ordersfoundnoreliablesecondarydistinctionbetweenfear
and other distress disorders (unrotated eigenvalues of 4.8
and 1.0 in developed countries and 4.3 and 1.3 in devel-
oping countries).
BIVARIATE AND MULTIVARIATE ASSOCIATIONS
BETWEEN EARLIER AND LATER DISORDERS
As noted, we estimated 306 bivariate survival equations,
eachwiththefirstonsetof1disorderpredictedbytheprior
Table 2. Prevalence and Rotated (Promax) Factor Pattern of Lifetime Disorders Separately in Developed
and Developing World Mental Health Countriesa
Disorder
Estimated Lifetime Prevalence (SD), %
Standardized Regression Coefficient, Survey Part
Developed
Countries
Developing
Countries Total
Developed
Countries
Developing
Countries Total
121212
Internalizing disorders
Agoraphobiab 1.8 (13.0) 1.0 (9.9) 1.3 (11.0) 0.87 −0.11 0.74 −0.16 0.82 −0.14
Bipolar I-II disorder 4.4 (22.9) 2.0 (15.1) 2.8 (18.3) 0.37 0.31 0.54 0.20 0.46 0.27
Generalized anxiety disorder 4.9 (22.0) 1.4 (12.5) 2.6 (16.8) 0.67 0.04 0.72 −0.02 0.69 0.05
Major depressive episode/dysthymia 17.5 (40.9) 9.4 (33.1) 12.0 (36.5) 0.72 0.07 0.69 0.09 0.71 0.09
Obsessive-compulsive disorder 6.9 (29.7) 5.8 (32.6) 6.2 (31.7) 0.51 0.12 0.71 −0.17 0.63 −0.04
Panic disorderc 3.4 (16.6) 0.7 (8.0) 1.6 (11.8) 0.65 0.10 0.51 0.17 0.60 0.17
Posttraumatic stress disorder 4.4 (25.4) 1.6 (14.8) 2.6 (19.5) 0.57 0.18 0.43 0.18 0.52 0.21
Separation anxiety disorder 5.8 (25.3) 5.5 (24.2) 5.6 (24.6) 0.54 0.20 0.47 0.14 0.50 0.15
Social phobia 7.7 (30.4) 2.6 (18.5) 4.3 (23.7) 0.72 0.09 0.74 −0.04 0.71 0.09
Specific phobia 10.4 (35.4) 7.1 (32.3) 8.2 (33.3) 0.75 −0.13 0.78 −0.16 0.79 −0.16
Externalizing disorders
Attention-deficit disorder 3.4 (23.5) 0.8 (9.5) 1.6 (15.8) 0.30 0.51 0.36 0.57 0.31 0.55
Hyperactivity disorder 2.7 (19.7) 0.6 (8.4) 1.3 (13.7) 0.19 0.58 0.32 0.60 0.22 0.61
Conduct disorder (overt)d 1.6 (15.3) 0.8 (9.2) 1.1 (11.6) −0.09 0.94 −0.03 0.90 −0.08 0.93
Conduct disorder (covert)e 4.5 (31.1) 1.8 (15.6) 2.7 (22.1) −0.04 0.90 0.05 0.84 −0.01 0.87
Intermittent explosive disorder 6.9 (32.5) 4.2 (28.1) 5.1 (29.9) 0.15 0.61 0.48 0.30 0.29 0.47
Oppositional defiant disorder 4.9 (34.0) 3.3 (20.9) 3.9 (26.1) 0.10 0.80 −0.02 0.73 0.02 0.78
Alcohol abusef 9.7 (42.3) 8.0 (34.7) 8.5 (37.5) 0.01 0.76 −0.14 0.63 −0.06 0.73
Drug abusee 6.4 (31.3) 2.7 (21.0) 3.9 (25.0) −0.06 0.79 −0.15 0.69 −0.08 0.77
No. of respondentsg 7360 13869 21229
aResults are based on principal axis factor analysis of tetrachoric correlation matrices estimated in person-year data sets. Disorders are defined by DSM-IV
criteria and the Composite International Diagnostic Interview.
bIndicates with or without panic disorder.
cIndicates with or without agoraphobia.
dIncludes, for example, bullying, fighting, and being physically cruel to people.
eIncludes, for example, lying and shoplifting.
fIndicates with or without dependence.
gThe numbers of person-years (every year of life of the respondents beginning at 4 years to the age at interview) are 214738 (developed countries),
376961 (developing countries), and 591699 (total).
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vivalcoefficients,98.0%werepositiveand95.1%werealso
significant (Table 3). (Detailed results are not reported
herein,butareavailablefromtheauthorsonrequest.)The
median(interquartilerange)ORswere3.4(2.7-4.3).None
of the negative ORs was significant. Within-domain ORs
were generally larger than between-domain ORs, with
within-domain median ORs of 3.6 to 5.5 compared with
between-domain medians of 3.0 to 3.2.
This largely positive pattern persisted in attenuated
form in multivariate models, with 80.0% of ORs posi-
tive and 43.0% positive and statistically significant
(Table3).Themedian(1.4)andinterquartilerange(1.1-
1.9)ofORswereconsiderablylowerthaninbivariatemod-
els because of strong intercorrelations among predictor
disorders. Nine of the 306 multivariate ORs were nega-
tiveandsignificant(GADpredictingagoraphobiaandspe-
cific phobia; HD, PTSD, and CD1 predicting OCD; CD2
predicting GAD and PTSD; and alcohol abuse predict-
ing ADD and HD). Of the within-domain ORs, 50.9% to
58.9%werepositiveandsignificantcomparedwith28.8%
to 33.8% of between-domain ORs. The median OR was
higher within (1.6) than between (1.3) domains.
MULTIVARIATE ASSOCIATIONS
IN THE LATENT VARIABLE MODEL
Thelatentvariablemodelfittheobserveddatabetterthan
the observed variable model, as indicated by a lower
Bayesian information criterion45 of 7514.3 (latent) vs
7530.0 (observed) and an insignificant improvement in
likelihood-ratio 2 of the observed variable model
(2
270=107.8;P=.99).Latentvariablecoefficientswerequite
stable,asindicatedbythePearsoncorrelationsofmodel
coefficients across 4 samples (the total sample and the 3
subsamples of all developed countries, all developing
countries, and all countries excluding the 4 with survey
response rates of less than 60% [Belgium, France, Ger-
many, and the Netherlands]) of 0.88 to 0.97. (Detailed
resultsarenotreportedherein,butareavailablefromthe
authors on request.)
Asnoted,thelatentvariablesareactuallyweighted(by
ORs of disorders predicting latent variables) compos-
itesofallpredictordisorders.Theassumptionthatasingle
weighted composite can represent the effects of all the
predictor disorders on all outcomes is equivalent to as-
suming that the ratios of the ORs across predictors are
constantacrossoutcomes.Thegoodfitofthelatentvari-
able model shows that this assumption is generally con-
sistentwiththedata,whichmeansthatthepredictiveef-
fects of these disorders on each other can plausibly be
assumed to be mediated by common internalizing and
externalizing pathways.
Themetricofthetimetlatentvariableswassetbyfix-
ing the slope of the latent variable on the strongest time
tpredictorto1.0andscalingotherslopesrelativetothat
value (Table 4). Within the internalizing domain, spe-
cificphobiawasbyfarthemostpowerfulpredictor(1.00
by definition), followed by OCD (0.62) and other pho-
bias (0.46-0.48) (Table 4). At the other extreme, GAD
andpanicdisorderwereinsignificantpredictors.There-
maining internalizing disorders had ORs of intermedi-
ate strength (0.18-0.44). Within the externalizing do-
main,HD(1.00)andODD(0.97)werethemostpowerful
predictors.Alcoholandotherdrugabusewereinsignifi-
cant,andtheremainingexternalizingdisordershadORs
in the range of 0.43 to 0.77.
The ORs for the disorders as outcomes were much
moreconsistentthanforthedisordersaspredictors,with
ranges of 0.68 to 1.00 (internalizing) and 0.44 to 1.00
Table 3. Associations of Lifetime Disorders With Subsequent First Onset of Other Disorders
Based on Bivariate and Multivariate Survival Models in the Total Samplea
Distribution of ORs
Median (Range) IQR Positive, %
Positive and
Significant, % No. of ORs
Internalizing predicting internalizing 90
Bivariate 3.6 (1.2-10.4) 3.0-4.3 100.0 97.8
Multivariate 1.6 (0.4-5.5) 1.1-2.0 87.8 58.9
Externalizing predicting internalizing 80
Bivariate 3.2 (1.7-7.5) 2.6-3.7 100.0 98.8
Multivariate 1.3 (0.5-3.2) 1.0-1.6 80.0 28.8
Internalizing predicting externalizing 80
Bivariate 3.0 (0.4-10.3) 2.4-3.9 96.3 90.0
Multivariate 1.3 (0.1-3.2) 0.9-1.6 70.0 33.8
Externalizing predicting externalizing 56
Bivariate 5.5 (0.5-30.0) 3.3-8.2 94.5 92.7
Multivariate 1.6 (0.2-13.4) 1.2-2.9 81.8 50.9
Total 306
Bivariate 3.4 (0.4-30.0) 2.7-4.3 98.0 95.1
Multivariate 1.4 (0.1-13.4) 1.1-1.9 80.0 43.0
Abbreviations: IQR, interquartile range; OR, odds ratio.
aFirst lifetime onset of each of 18 DSM-IV/Composite International Diagnostic Interview disorders was predicted by a single dummy variable for lifetime history
of 1 of the other disorders (bivariate model) or 17 dummy variables for history of each of the 17 other disorders (multivariate model) in discrete-time
(person-year) survival models. The predictor disorders and latent variables were treated as time-varying covariates. Controls were included for respondent age at
interview, person-year, sex, and country. Data include 21229 respondents.
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moststronglypredictedinternalizingdisorders,whereas
ADDandHDwerethemoststronglypredictedexternal-
izingdisorders.Therelativeimportanceofinternalizing
andexternalizingdisorderspredictingeachotherwases-
timated in the set of 4 ORs between the latent variables
at times t and t1( Table 5). Weighted (by relative
prevalenceofdisorders)within-domainORs(1.6forin-
ternalizing; 1.4 for externalizing) were higher than be-
tween-domain ORs (1.3 for time t internalizing predict-
ing time t1 externalizing; 1.1 for time t externalizing
predicting time t1 internalizing), but between-
domain ORs were nonetheless statistically significant.
RESIDUAL ASSOCIATIONS NOT EXPLAINED
BY THE LATENT VARIABLE MODEL
Only 13 of the 306 residual pairwise time-lagged associa-
tionsbetweenobserveddisorderspassedourtestofstatis-
tical significance. Nine of these were positive. Four in-
volved within-disorder reciprocal ORs between CD1 and
CD2(3.2-4.8)andbetweenADDandHD(4.0-19.4).Two
others involved asymmetrical associations between well-
knowndisorderpairs(panicpredictingagoraphobia[2.0-
2.22] and depression predicting GAD [2.0-6.0], although
the latter association was limited to child-adolescent on-
set).Twoothersmightreflectdiagnosticconfusions,with
agoraphobia predicting specific phobia (2.2-4.8) and HD
(but,importantly,notADD)predictingBPD(1.9-3.9).The
final significant positive association was for IED predict-
ing OCD (1.5-4.0). The 4 significant negative residual as-
sociationsincludedPTSDpredictingOCD(0.4-0.7),CD2
predictingBPD(0.2-0.5)andPTSD(0.2-0.4),andIED(0.5-
0.6) predicting drug abuse.
COMMENT
Sixlimitationsofthisstudyarenoteworthy.First,diagnoses
were based on fully structured lay interviews. These typi-
callyproducemorereliable(ie,reproducibleacrossmultiple
interviewers)diagnosesthansemistructuredclinicalinter-
views,46andtheirprevalenceestimatestypicallycorrespond
wellwiththosebasedonclinicalinterviews.47However,fully
structuredinterviews,unlikesemistructuredclinicalinter-
views,areunabletoclarifysymptomresponsesorcheckques-
tionsacrossdisorderstofacilitatedifferentialdiagnosis,po-
tentially leading to inflated estimates of comorbidity.
Second,disorderswereassesseddichotomouslyrather
than dimensionally, presumably reducing our ability to
detect subtle aspects of structure in the data. This might
helpexplainwhywedidnotdetecthigher-ordersubfac-
tors in the 2-factor exploratory factor analysis model.
Third,datawerecombinedacrosscountrieswithvery
different cultures and across surveys with very different
response rates (which could have introduced variation
in sample selection bias), different rates of sample ex-
clusion(duetocross-nationaldifferencesinratesofsui-
cide,homelessness,andinstitutionalization),anddiffer-
ent languages in which interviews were administered.
Although every effort was made to make the transla-
tions as comparable as possible,34 residual variation in
meaning almost certainly contributed to cross-national
variation in results.
Table 4. Parameter Estimates for Associations Between Observed Disorders and Latent Variables in the Latent Variable Modela
Disorder
Estimate (SE)
Time t Disorders Predicting
Time t Latent Variables
Time t1 Latent Variables Predicting
Time t1 First Onset of Disorders
Internalizing
Agoraphobia 0.48 (0.09)b 1.00 (0.09)b
Bipolar I/II disorder 0.18 (0.08)b 0.85 (0.05)b
Generalized anxiety disorder 0.02 (0.07) 0.72 (0.05)b
Major depressive episode 0.29 (0.06)b 0.68 (0.04)b
Obsessive-compulsive disorder 0.62 (0.07)b 0.87 (0.06)b
Panic disorder −0.02 (0.10) 0.82 (0.05)b
Posttraumatic stress disorder 0.21 (0.08)b 0.68 (0.05)b
Separation anxiety disorder 0.44 (0.06)b 0.74 (0.05)b
Social phobia 0.46 (0.05)b 0.97 (0.05)b
Specific phobia 1.00 (0.09)b 0.86 (0.10)b
Externalizing
Attention-deficit disorder 0.77 (0.24)b 1.00 (0.31)b
Hyperactivity disorder 1.00 (0.23)b 0.95 (0.16)b
Conduct disorder (overt) 0.43 (0.18)b 0.74 (0.16)b
Conduct disorder (covert) 0.57 (0.23)b 0.78 (0.16)b
Intermittent explosive disorder 0.77 (0.15)b 0.52 (0.08)b
Oppositional defiant disorder 0.97 (0.18)b 0.69 (0.15)b
Alcohol abuse disorder −0.53 (0.35) 0.44 (0.08)b
Drug abuse disorder 0.51 (0.31) 0.38 (0.13)b
aBased on an iteratively estimated pooled discrete-time (person-year) survival model with 17 dummy variables for history of each other disorder predicting
subsequent first onset of each of the 18 disorders, assuming the existence of latent internalizing and externalizing disorders that explain the direct effects of the
observed predictor disorders on the outcome disorders. The predictor disorders and latent variables were treated as time-varying covariates. Controls were
included for respondent age at interview, person-year, sex, and country. Data include 21229 respondents.
bSignificant at the .05 level, 2-sided test.
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tive reports rather than prospective assessments, prob-
ably leading to recall bias that underestimated preva-
lence48anddistortedage-at-onsetestimates49despitethe
useofspecialmemory-primingmethods.38Biasinmodel
coefficientsmighthavevariedacrossdisordersasafunc-
tion of age at onset and/or recency. Given the impor-
tance of this potential bias, it is noteworthy that the on-
setdistributionsbasedontheseretrospectivedataarequite
consistent with those based on prospective studies and
studies performed at separate life course stages.50 In ad-
dition, model coefficients in subsamples defined by life
course stage are very consistent, suggesting that varia-
tion in recall across the sample age range does not in-
fluence results in any important way.
Fifth, models were based on the simplifying assump-
tionsthatthetime-laggedassociationsamongmentaldis-
ordersareconstantacrosscountriesandsex,stableacross
thelifecourse,andunrelatedtoageatonsetortimesince
onset of the predictor disorders. Preliminary analyses
showed that these assumptions are a reasonable first ap-
proximation, but the investigation of these specifica-
tions needs to be a focus of ongoing WMH analysis.
Sixth, we did not take history of treatment into con-
sideration even though early treatment, which varies in
frequency across countries,51 might interrupt the pro-
gression of comorbidity and thereby distort estimates of
predictive associations.
Inthecontextoftheselimitations,ourfindingofa2-fac-
torinternalizing-externalizingstructureamongWMHdis-
orders is consistent with previous research4-9 but does not
support the distinction in some previous studies between
distress(eg,depression,GAD,andPTSD)andfear(eg,panic
andphobias)disorders.Asnotedintheintroduction,oth-
ersalsofailedtofindadistinctionbetweendistressandfear
disorders.16,52Thisless-differentiatedstructureintheWMH
datamightbeduetoourfocusonlifetimedisorders,whereas
12-monthdisorderswerethefocusofmoststudiesthatdis-
tinguished distress and fear disorders.
Our finding of significant time-lagged associations
acrossvirtuallyallpairsofthedisordersconsideredherein
is broadly consistent with evidence of associations be-
tween earlier and later disorders in previous longitudi-
nal studies,18-23 although most previous studies focused
on prevalent cases, whereas we studied first onsets. We
found, again consistent with previous studies, stronger
andmoreconsistenttime-laggedassociationswithinthan
between the internalizing and externalizing domains.
However,againasinpreviousstudies,wealsofoundsig-
nificant between-domain time-lagged associations.22,23
Our analysis went beyond previous studies to investi-
gate the role of latent variables in the development of co-
morbidity.Weshowedthatmostofthe306pairwisetime-
lagged associations among the 18 disorders considered
herein can be explained by a model that assumes the exis-
tence of mediating latent internalizing and externalizing
variables.Thisfindingextendspreviouscross-culturalwork
onthestructureofcomorbidity.53Thefactthatthepredic-
tive associations across this large number of disorders are
mediated by 2 higher-order variables makes the internal-
izing and externalizing spectrum dimensions compelling
targets for inquiry aimed at reducing the burden of men-
tal disorder around the world by interrupting the pro-
cesses leading to the onset of comorbidity.
Specific phobia and OCD stood out as the most im-
portantinternalizingpredictorsandHDandODDasthe
most important externalizing predictors. The time-
lagged associations involving these 4 predictors were
largely mediated by the latent variables, with only 2 of
the 13 significant residual associations involving these
4 strongest predictors (HD predicting ADD and BPD).
Both of these were positive, showing that the compar-
atively high ORs of these 4 predictor disorders are rela-
tively constant across the range of WMH outcomes. Al-
thoughitisunclearwhyspecificphobiaandOCDshould
be the most important predictors among the internaliz-
ing disorders or HD and ODD among the externalizing
disorders, the fact that all 4 are typically early-onset dis-
orders50 means they might be useful markers of youth at
highriskforprogressiontolaterdisorders.Eventhispos-
sibilityrequiresfurtheranalysis,however,becausewedid
not investigate nonproportional hazards that might in-
clude differential predictive associations related to age
at onset or time since onset. These more in-depth analy-
ses go beyond the scope of this first report but will be
pursued in ongoing WMH analyses.
Ourfindingof13significantresidualassociationsshows
thatthelatentvariablesdonotexplainallthecomorbidity
among the disorders considered. The 4 negative residual
associations are most plausibly interpreted as suggesting
the existence of more differentiated dimensions underly-
ing internalizing and externalizing disorders. The nega-
tiveassociationofIEDwithsubsequentdrugabuse,forex-
ample,couldbeduetoexternalizingdisordersbeingmade
up of multiple dimensions, 1 or more of which is signifi-
cantlymorestronglyrelatedtodrugabusethantoIED.Evi-
dence consistent with this possibility exists in the litera-
ture.54-56 The negative residual association of CD2 (overt
CD) with subsequent PTSD, in comparison, might be re-
latedtothefindingsthatbluntedpsychophysiologicaland
emotionalreactivitytofearstimuliarepredictorsofCD,57,58
whereas heightened physiological reactivity to trauma-
related stress cues is a predictor of PTSD.59,60These obser-
vations suggest that a more differentiated latent variable
model that includes internalizing and externalizing sub-
dimensionsmightexplainthesignificantnegativeassocia-
tions found herein in the less differentiated WMH latent
variable model.
The positive residual associations in the WMH data,
in comparison, are most plausibly interpreted as disor-
Table 5. Parameter Estimates for Associations Among
Latent Variables in the Latent Variable Modela
Time 1 Predictor
Group
Time 2 Dependent Group,
OR (95% CI)b
Internalizing Externalizing
Internalizing 1.6 (1.5-1.6) 1.3 (1.2-1.3)
Externalizing 1.1 (1.1-1.2) 1.4 (1.3-1.4)
Abbreviations: CI, confidence interval; OR, odds ratio.
aData include 21229 respondents.
bAll comparisons were significant at the .05 level, 2-sided test.
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ciprocalassociationsbetweenCD1(covertCD)andCD2
(overt CD) and between ADD and HD, or as a severity
markerintheassociationbetweenpanicdisorderandsub-
sequent agoraphobia. At least 1 other association, be-
tweenagoraphobiaandsubsequentspecificphobia,could
beduetodiagnosticconfusionintheCIDI.Thesamekind
of confusion might account at least in part for the posi-
tive association between HD and subsequent BPD be-
cause differentiation between these 2 disorders can be
difficult,especiallywithintheconstraintsofafullystruc-
tureddiagnosticinterview,61,62althoughanumberofcom-
monneurobiologicalcorrelateshavealsobeenfoundfor
HD and BPD,63,64 arguing that ADHD might be a risk
marker of BPD. The WMH finding that this association
is specific to HD and does not apply to ADD has not, to
our knowledge, been investigated previously.
It is important to caution that these few unique, sig-
nificant residual pairwise associations should be treated
asnomorethanpreliminaryowingtotheproblemofmul-
tiple testing and the limitations noted at the beginning
of this section. Replication in other data sets, most im-
portantlyprospectivedatasets,isneededbeforetheseas-
sociations should be considered reliable. Furthermore,
even if they are subsequently found to be reliable, their
existenceshouldnotdeflectattentionfromourmainfind-
ingthattheconsistentlysignificantcomorbiditiesfound
amongthe306disorderpairsconsideredhereinarelikely
due to common underlying processes that should be a
majorfocusoffutureresearchonthedevelopmentofco-
morbidity. One important implication of this finding is
that future research on specific pairwise comorbid asso-
ciations needs to guard against interpreting results as
uniquewithoutfirstdemonstrating,aswedidherein,that
they are specific rather than mere realizations of larger
processes involving all internalizing and/or externaliz-
ing disorders. The fact that we found only 2 factors, fi-
nally, does not mean that only 2 underlying processes
are at work because multiple processes could underlie
each factor, and these diverse processes need to be stud-
ied to enrich our understanding of the causal influences
leading to the higher-order structure found herein.
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